These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21767245)

  • 21. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the true number of lymph nodes in lymphadenectomy specimens from radical cystectomy.
    Jensen JB; Ulhøi BP; Jensen KM
    Scand J Urol Nephrol; 2009; 43(4):288-92. PubMed ID: 19437191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP
    Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.
    Capitanio U; Suardi N; Shariat SF; Lotan Y; Palapattu GS; Bastian PJ; Gupta A; Vazina A; Schoenberg M; Lerner SP; Sagalowsky AI; Karakiewicz PI
    BJU Int; 2009 May; 103(10):1359-62. PubMed ID: 19076140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does extended lymph node dissection affect the lymph node density and survival after radical cystectomy?
    Dharaskar A; Kumar V; Kapoor R; Jain M; Mandhani A
    Indian J Cancer; 2011; 48(2):230-3. PubMed ID: 21768672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
    Fleischmann A; Thalmann GN; Markwalder R; Studer UE
    J Clin Oncol; 2005 Apr; 23(10):2358-65. PubMed ID: 15800327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
    May M; Herrmann E; Bolenz C; Tiemann A; Brookman-May S; Fritsche HM; Burger M; Buchner A; Gratzke C; Wülfing C; Trojan L; Ellinger J; Tilki D; Gilfrich C; Höfner T; Roigas J; Zacharias M; Gunia S; Wieland WF; Hohenfellner M; Michel MS; Haferkamp A; Müller SC; Stief CG; Bastian PJ
    Eur Urol; 2011 May; 59(5):712-8. PubMed ID: 21296488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F; Brunocilla E; Bertaccini A; Guidi M; Pernetti R; Morselli-Labate AM; Martorana G
    Anticancer Res; 2010 Jul; 30(7):2973-6. PubMed ID: 20683041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
    Heck MM; Koll FJ; Retz M; Autenrieth M; Magg K; Lunger L; Gschwend JE; Nawroth R
    Urol Oncol; 2020 Jul; 38(7):639.e11-639.e19. PubMed ID: 32146127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
    Schilling D; Hennenlotter J; Gakis G; Schwentner C; Kuehs U; Stenzl A; Sotlar K
    BJU Int; 2012 Sep; 110(6 Pt B):E166-71. PubMed ID: 22314026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separate submission of standard lymphadenectomy in 6 packets versus en bloc lymphadenectomy in bladder cancer.
    Ather MH; Alam Z; Jamshaid A; Siddiqui KM; Sulaiman MN
    Urol J; 2008; 5(2):94-8. PubMed ID: 18592461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of lymphadenectomy in high-grade invasive bladder cancer.
    Stein JP; Skinner DG
    Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
    Shariat SF; Ehdaie B; Rink M; Cha EK; Svatek RS; Chromecki TF; Fajkovic H; Novara G; David SG; Daneshmand S; Fradet Y; Lotan Y; Sagalowsky AI; Clozel T; Bastian PJ; Kassouf W; Fritsche HM; Burger M; Izawa JI; Tilki D; Abdollah F; Chun FK; Sonpavde G; Karakiewicz PI; Scherr DS; Gonen M
    Eur Urol; 2012 Feb; 61(2):237-42. PubMed ID: 22033174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.
    Kurahashi T; Hara I; Oka N; Kamidono S; Eto H; Miyake H
    Clin Cancer Res; 2005 May; 11(10):3773-7. PubMed ID: 15897575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.